Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Jan 26, 2026
Sale
Shares
14,625
Price
$471.91
Total Value
$6.90M
Shares Held After
0
% of Holdings
100.0%

Liquidia Corp (LQDA)

Boyle Dana — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
1,580
Price
$41.65
Total Value
$65.81K
Shares Held After
178,848
% of Holdings
0.9%

Liquidia Corp (LQDA)

Adair Jason — Chief Business Officer
Jan 26, 2026
Sale
Shares
688
Price
$41.65
Total Value
$28.66K
Shares Held After
211,169
% of Holdings
0.3%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 26, 2026
Sale
Shares
6,418
Price
$5.02
Total Value
$32.22K
Shares Held After
593,185
% of Holdings
1.1%

Milestone Pharmaceuticals Inc. (MIST)

Bharucha David — Chief Medical Officer
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
113,181
% of Holdings
9.8%

Milestone Pharmaceuticals Inc. (MIST)

Nelson Jeffrey Edward — Chief Operating Officer
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
49,848
% of Holdings
19.7%

Milestone Pharmaceuticals Inc. (MIST)

Muller Lorenz — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
11,180
Price
$1.93
Total Value
$21.58K
Shares Held After
205,406
% of Holdings
5.2%

Milestone Pharmaceuticals Inc. (MIST)

Hasija Amit — CFO & EVP of Corp. Development
Jan 26, 2026
Sale
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
99,848
% of Holdings
10.9%
Jan 26, 2026
Sale
Shares
34,523
Price
$1.93
Total Value
$66.63K
Shares Held After
482,744
% of Holdings
6.7%
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
279,481
% of Holdings
4.2%
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
19,618
% of Holdings
59.7%
Jan 26, 2026
Sale
Shares
14,205
Price
$84.05
Total Value
$1.19M
Shares Held After
574,505
% of Holdings
2.4%
Jan 26, 2026
Sale
Shares
10,685
Price
$84.00
Total Value
$897.54K
Shares Held After
574,505
% of Holdings
1.8%

Protagonist Therapeutics, Inc (PTGX)

MOLINA ARTURO MD — Chief Medical Officer
Jan 26, 2026
Sale
Shares
5,000
Price
$82.28
Total Value
$411.40K
Shares Held After
84,115
% of Holdings
5.6%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
309
Price
$33.45
Total Value
$10.34K
Shares Held After
24,353
% of Holdings
1.3%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 26, 2026
Sale
Shares
34,091
Price
$32.77
Total Value
$1.12M
Shares Held After
24,662
% of Holdings
58.0%
Jan 26, 2026
Sale
Shares
26,918
Price
$4.61
Total Value
$124.09K
Shares Held After
1,317,389
% of Holdings
2.0%
Jan 26, 2026
Sale
Shares
41,312
Price
$4.61
Total Value
$190.45K
Shares Held After
2,908,257
% of Holdings
1.4%

Taysha Gene Therapies, Inc. (TSHA)

Alam Kamran — CHIEF FINANCIAL OFFICER
Jan 26, 2026
Sale
Shares
23,849
Price
$4.61
Total Value
$109.94K
Shares Held After
1,443,786
% of Holdings
1.6%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Jan 26, 2026
Sale
Shares
1,053
Price
$96.19
Total Value
$101.29K
Shares Held After
43,741
% of Holdings
2.4%

Mirum Pharmaceuticals, Inc. (MIRM)

Radovich Peter — PRESIDENT AND COO
Jan 26, 2026
Sale
Shares
3,143
Price
$96.19
Total Value
$302.33K
Shares Held After
23,286
% of Holdings
11.9%

Mirum Pharmaceuticals, Inc. (MIRM)

Howe Jolanda — SVP, GLOBAL CONTROLLER
Jan 26, 2026
Sale
Shares
842
Price
$96.19
Total Value
$80.99K
Shares Held After
3,700
% of Holdings
18.5%
Jan 26, 2026
Sale
Shares
6,831
Price
$96.19
Total Value
$657.09K
Shares Held After
169,402
% of Holdings
3.9%

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Huntsman Carole — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
570
Price
$494.59
Total Value
$281.92K
Shares Held After
9,122
% of Holdings
5.9%

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Huntsman Carole — Chief Commercial Officer
Jan 26, 2026
Sale
Shares
340
Price
$492.42
Total Value
$167.42K
Shares Held After
9,692
% of Holdings
3.4%
Jan 26, 2026
Sale
Shares
1,577
Price
$492.42
Total Value
$776.55K
Shares Held After
148,497
% of Holdings
1.1%
Jan 26, 2026
Sale
Shares
647
Price
$492.42
Total Value
$318.60K
Shares Held After
452,704
% of Holdings
0.1%
Jan 23, 2026
Sale
Shares
8,135
Price
$30.01
Total Value
$244.15K
Shares Held After
419,173
% of Holdings
1.9%
Jan 23, 2026
Sale
Shares
19,315
Price
$84.59
Total Value
$1.63M
Shares Held After
574,505
% of Holdings
3.3%

Protagonist Therapeutics, Inc (PTGX)

MOLINA ARTURO MD — Chief Medical Officer
Jan 23, 2026
Sale
Shares
13,151
Price
$82.42
Total Value
$1.08M
Shares Held After
84,115
% of Holdings
13.5%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 23, 2026
Sale
Shares
12,767
Price
$34.37
Total Value
$438.80K
Shares Held After
24,353
% of Holdings
34.4%

NewAmsterdam Pharma Co N.V. (NAMS)

Kooij Louise Frederika — Chief Accounting Officer
Jan 23, 2026
Sale
Shares
25,405
Price
$33.44
Total Value
$849.54K
Shares Held After
37,120
% of Holdings
40.6%
Jan 23, 2026
Purchase
Shares
131,425
Price
$68.48
Total Value
$9.00M
Shares Held After
459,010
% of Holdings
28.6%
Jan 23, 2026
Sale
Shares
89,132
Price
$4.75
Total Value
$423.38K
Shares Held After
1,344,307
% of Holdings
6.2%
Jan 23, 2026
Sale
Shares
136,789
Price
$4.75
Total Value
$649.75K
Shares Held After
2,949,569
% of Holdings
4.4%

Taysha Gene Therapies, Inc. (TSHA)

Alam Kamran — CHIEF FINANCIAL OFFICER
Jan 23, 2026
Sale
Shares
78,968
Price
$4.75
Total Value
$375.10K
Shares Held After
1,467,635
% of Holdings
5.1%

Royalty Pharma plc (RPRX)

Urist Marshall — EVP, Research & Investments
Jan 23, 2026
Sale
Shares
20,000
Price
$40.26
Total Value
$805.11K
Shares Held After
20,000
% of Holdings
50.0%
Jan 23, 2026
Purchase
Shares
1,151
Price
$55.98
Total Value
$64.43K
Shares Held After
449,844
% of Holdings
0.3%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 23, 2026
Sale
Shares
5,556
Price
$5.27
Total Value
$29.28K
Shares Held After
599,603
% of Holdings
0.9%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 23, 2026
Sale
Shares
5,633
Price
$1.90
Total Value
$10.72K
Shares Held After
173,999
% of Holdings
3.1%

CRISPR Therapeutics AG (CRSP)

Prasad Raju — Chief Financial Officer
Jan 22, 2026
Sale
Shares
34,972
Price
$60.19
Total Value
$2.10M
Shares Held After
6,767
% of Holdings
83.8%
Jan 22, 2026
Sale
Shares
250,000
Price
$40.00
Total Value
$10.00M
Shares Held After
6,494,962
% of Holdings
3.7%

ABEONA THERAPEUTICS INC. (ABEO)

Vasanthavada Madhav — Chief Commercial Officer
Jan 22, 2026
Sale
Shares
12,610
Price
$5.29
Total Value
$66.66K
Shares Held After
318,619
% of Holdings
3.8%
Jan 22, 2026
Sale
Shares
3,828
Price
$18.10
Total Value
$69.30K
Shares Held After
210,164
% of Holdings
1.8%

Bicara Therapeutics Inc. (BCAX)

Hyep Ivan — Chief Financial Officer
Jan 22, 2026
Sale
Shares
1,882
Price
$18.15
Total Value
$34.16K
Shares Held After
145,355
% of Holdings
1.3%

Maze Therapeutics, Inc. (MAZE)

Bachrodt Amy — SVP, Finance
Jan 22, 2026
Sale
Shares
5,000
Price
$45.52
Total Value
$227.61K
Shares Held After
12,965
% of Holdings
27.8%

Beam Therapeutics Inc. (BEAM)

Cavanagh Bethany J — SVP, Finance and Treasurer
Jan 22, 2026
Sale
Shares
6,198
Price
$35.00
Total Value
$216.93K
Shares Held After
34,813
% of Holdings
15.1%

Beam Therapeutics Inc. (BEAM)

Bellon Christine — Chief Legal Officer
Jan 22, 2026
Sale
Shares
1,371
Price
$34.00
Total Value
$46.61K
Shares Held After
95,667
% of Holdings
1.4%

CEL SCI CORP (CVM)

KERSTEN GEERT R — Director
Jan 22, 2026
Purchase
Shares
38,023
Price
$5.26
Total Value
$200.00K
Shares Held After
120,815
% of Holdings
31.5%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Jan 22, 2026
Sale
Shares
2,500
Price
$2.95
Total Value
$7.38K
Shares Held After
0
% of Holdings
100.0%
Version: v26.3.33